Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective

Rebecca J Brown1, Patrick Nguipdop-Djomo2, Hongxin Zhao3

  • 1Public Health EnglandLondon, UK; Department of Child Health, University Hospital Wales, Cardiff University School of MedicineCardiff, UK.

Frontiers in Microbiology
|February 25, 2016
PubMed

Insights

Mycoplasma pneumoniae, a respiratory pathogen, causes pneumonia and severe complications like encephalitis, particularly in children. England has observed ~4-yearly epidemic cycles and winter seasonal peaks since the 1970s.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae is a significant respiratory pathogen causing pneumonia and potential sequelae like encephalitis.
  • Prevalence is highest in children aged 5-14 years.
  • England has documented recurrent epidemic periods approximately every 4 years, alongside seasonal peaks in winter.

Purpose of the Study:

  • To analyze epidemiological trends of Mycoplasma pneumoniae infections in England.
  • To review data from 1975 to 2015, including laboratory reports and hospital submissions.
  • To incorporate molecular typing data for cases from 2005 to 2015.

Main Methods:

  • Collated voluntary reports from regional laboratories and hospitals across England.
  • Utilized data from 1975 to 2015 for epidemiological analysis.
  • Included case data and specimen submissions to Public Health England from 2005 to 2015.

Main Results:

  • Confirmed recurrent epidemic periods of M. pneumoniae infection in England at approximately 4-year intervals.
  • Identified seasonal peaks of infection occurring from December to February.
  • Documented the pathogen's presence across all age groups, with a notable higher prevalence in children aged 5-14.

Conclusions:

  • Mycoplasma pneumoniae exhibits distinct epidemic and seasonal patterns in England.
  • The pathogen remains a significant public health concern, particularly for pediatric populations.
  • Long-term surveillance provides valuable insights into infection dynamics and epidemiology.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
17
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
60